Biocon enhances partnership with Mylan for insulin products
Mylan and Biocon will share development, capital and certain other costs to bring the products to market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Aurobindo Pharma receives US FDA approvals
Pioglitazone and Pioglitazone Hydrochloride + Metformin Hydrochloride tabs are ready for launch
Sun Pharma and Taro announce termination of proposed transaction
Termination was in best interest of respective companies and shareholders
Sanofi India launches Combiflam Plus
The launch of this new product marks the company’s foray into the OTC headache segment in India
GGEl launches first generic Atovaquone Proguanil in the UK
Launch follows the revocation of the Malarone patent in the High court in the UK
Pharmexcil to open warehouse facility in Nigeria
To provide subsidised facilities to all its members
IPM grows at 9.8 per cent in January 2013
From a therapy perspective 11 therapies have outgrown the IPM growth
Victoria life science cos explore India market
Members of the delegation to harness synergies between Melbourne’s life sciences infrastructure and India’s capabilities in…
NIPER celebrates Foundation Day
National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Mohali recently celebrated its Foundation Day at…
SPAIN PHARMA Seeking New Growth Avenues
The Eurozone crisis and subsequent recession in EU impacted the pharma market in Spain. Usha Sharma reports how the bounce back of…
’We are in talks with leading pharma companies to introduce Elores in South Africa and later…
Dr Manu Chaudhary, Joint Managing Director and Director—Research, Venus Remedies shares the company's marketing and branding…
Pharmexcil invites comments from industry on EU directive notification
Final notification to be issued by February 20-21, 2013
Q3 results posts ups and downs in India pharma sector
Indian pharma companies have posted their third quarter results. Express Pharma highlights the results
New rules on compensation to make clinical trials in India ‘virtually impossible’: ISCR
Notification goes against consensus reached in stakeholder meetings on two crucial criteria, alleges ISCR
Medicines Compendium expands global reach through new expert committees, enhanced website
Experts from Argentina, Bangladesh, Brazil, China, Korea, Pakistan and the UK reflect growth of the MC
Marck Biosciences takes private equity route with Tata Capital
To invest Rs 80 crores in new project
Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40
GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule
M&A activity in pharma sector focuses on expanding product offerings
January 2013 registers slight increase in volume terms and decrease in value terms
STEM-2013 redefines stem cell research in India
Researchers from France, Argentina and Brazil provided useful inputs about the regulatory scenario
GIPC-2013 sees congregation of IP experts
More than 300 speakers from 30 countries participated in the event